OBJECTIVE: We evaluated the rates of response, operability and long term survival and
toxicities in a large series of locally advanced cervical cancer (LACC) patients administered …

Background The efficacy of adjuvant therapy for patients with cervical cancer with
intermediate risk (CC‐IR) remains controversial. We examined the impact of adjuvant …

OBJECTIVE: Preoperative chemoradiation (CT/RT) has been shown to achieve encouraging
results in terms of clinical outcome in locally advanced cervical cancer (LACC). The study …

Objectives To retrospectively assess the influence of radical surgery following concurrent
chemoradiotherapy (CCRT) on outcomes in cervical cancer (CC) patients. Methods Patients …

Background To investigate whether carboplatin-liposomal paclitaxel neoadjuvant
chemotherapy (NACT) benefits patients with locally advanced cervical cancer (LACC) …

Objective: To assess the efficacy and toxicity profile of dose-dense cisplatin-based
neoadjuvant chemotherapy (NACT) followed by radical surgery in patients affected by …

Background: Chemoradiotherapy (CRT) is the standard of care for locally advanced cervical
cancer (LACC). Pre-treatment lymph nodes (LN) assessment may have an important …

OBJECTIVE: We recently published results of a phase III trial demonstrating superior
outcomes in patients with locally advanced cervical cancer (LACC) when concurrent …

Objective To evaluate the efficacy and safety of cisplatin-based concurrent
chemoradiotherapy (DDP-CCRT) in patients with high-risk cervical carcinoma (CC) …

Abstract Purpose The Gynecologic Oncology group (GOG) 0263 trial is currently exploring
whether adding chemotherapy to adjuvant radiotherapy improves recurrence-free and/or …